Connect Sign In
A better estimate of menopausal status will help providers and patients address both the symptoms of menopause and the associated risks, such as cardiovascular disease and osteoporosis. |
February 22, 2024 |
ARUP Offers FDA-Cleared Menopausal Status Test That May Help Women Protect Their Future Health The MenoCheck test helps providers treat women who are experiencing menopausal transition and manage |
Lupus anticoagulant testing aids in the diagnosis of autoimmune blood clotting disorders. |
February 20, 2024 |
Lupus Anticoagulant Test Neutralizes Interferences to Aid in Diagnosis of Antiphospholipid Syndrome… ARUP’s new lupus anticoagulant panel neutralizes several interfering anticoagulants to |
ARUP medical directors and scientists, including (from left to right) Sherin Shaaban, MD, PhD, FACMG; Yuan Ji, PhD, MBA, DABCP, FACMG; and Hunter Best, PhD, FACMG, along with others, will present their latest research and share insights for current and future geneticists at the Annual Clinical Genetics Meeting in March. |
February 15, 2024 |
ARUP medical directors and scientists will discuss the latest in pharmacogenomics, RNA |
Four different algorithms to lead clinicians through the correct approach to thyroid testing are available on arupconsult.com. |
January 16, 2024 |
ARUP’s In-Depth Information on Thyroid Disease Testing Helps Clinicians and… Lab testing is key to thyroid disease diagnosis and proper treatment but can be challenging |
Melanie Mallory, MS, lead bioinformatics scientist at ARUP Laboratories, played a key role in the development and validation of ARUP’s Cytomegalovirus Drug Resistance by Next Generation Sequencing assay. |
December 19, 2023 |
Next Generation Sequencing Assay Enables Earlier Detection of Drug-Resistant Cytomegalovirus… Next generation sequencing provides a more rigorous and sensitive method to identify drug- |
AAV5 DetectCDx™ detects the presence of anti-AAV5 antibodies to aid in the selection of patients eligible for the treatment ROCTAVIAN™. |
November 10, 2023 |
EU Approval of AAV5 DetectCDx™ Provides Access to Companion Diagnostic for Hemophilia A Gene Therapy ARUP has gained a Conformité Européenne (CE) mark for AAV5 DetectCDx™ single-site use. The test |
ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™ We accelerate the development and adoption of cutting-edge diagnostic and prognostic technologies advancing patient care through groundbreaking science and engineering. The Sherrie Perkins Research and Innovation Collaboration Grant The Sherrie Perkins Research and Innovation Collaboration Grant funds cutting-edge research in laboratory medicine.
Test Information
